Singapore - English - HSA (Health Sciences Authority)

mandarin opto-medic co pte ltd - ophthalmology - the mr q ophthalmic laser is intended to perform posterior capsulotomy, iridotomy and pupillary membranectomy.

European Union - English - EMA (European Medicines Agency)

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - ophthalmologicals - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv)

European Union - English - EMA (European Medicines Agency)

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - ophthalmologicals - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv)

New Zealand - English - Medsafe (Medicines Safety Authority)

samsung bioepis nz limited - ranibizumab 10 mg/ml - solution for injection - 10 mg/ml - active: ranibizumab 10 mg/ml excipient: histidine histidine hydrochloride monohydrate polysorbate 20 trehalose dihydrate water for injection - byooviz is indicated for: - the treatment of neovascular (wet) age-related macular degeneration (amd), - the treatment of visual impairment due to diabetic macular oedema (dme), - treatment of proliferative diabetic retinopathy (pdr), - the treatment of visual impairment due to choroidal neovascularisation (cnv), - the treatment of visual impairment due to choroidal neovascularisation (cnv) secondary to pathologic myopia (pm), - the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo).

Australia - English - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - 37973 - x-ray system, diagnostic, fluoroscopic, general-purpose, application program software - the product is intended to provide the following functions: to be downloadable from the internet and to be unlocked using an mdt provided key; grant access rights only to authorized users (via pc password system); receive x-ray images in a proprietary digital format from third party x-ray machines or x-ray digitizers; process such images securely with respect to patient confidentiality, patient identification and image integrity; allow the image to be retrieved for processing as follows: scaling of the image selection of appropriate prosthetic manufacturer and size range templates overlaying the template on the image and permitting selection of appropriate size of prosthetic print and archive appropriate reports operation of osteotomy and trauma (fracture reduction modules) operation of spine module ? refer to associated change request record for specific technical description and connection to the development issues database receive and store templates for prostheses supplied by mdt for particular manufac

Singapore - English - HSA (Health Sciences Authority)

good pharmaceutical pte. ltd. - epinephrine - injection - 1.10mg/ml (includes a 10% overage) - epinephrine 1 mg/ml

Singapore - English - HSA (Health Sciences Authority)

good pharmaceutical pte. ltd. - epinephrine - injection - 0.55mg/ml (includes a 10% overage) - epinephrine 0.5 mg/ml

India - English - Central Drugs Standard Control Organization

meridian ent. - 60g

India - English - Central Drugs Standard Control Organization

meridian ent. - benzalkonium chl. - 3%(aq base q.s.) - 100/500;ml

India - English - Central Drugs Standard Control Organization

meridian ent. - 10